How Trump's tariffs pushed a UK pharma giant to slash US prices
Astrazeneca has bowed to pressure from US president Donald Trump to lower the cost of its medicines for patients in America. The Cambridge-based pharma giant said it will provide direct-to-consumer sales to eligible patients with prescriptions for chronic diseases at a discount of up to 80 per cent off list prices. The firm is also getting involved with the US government’s new direct purchasing platform, which will allow patients to purchase medicines at a reduced cash price. Astrazeneca said the move, which meets the stringent new requirements Trump has imposed on pharma businesses, would allow it to swerve any tariffs imposed on the sector for at least the next three years. Read more of the story here 👇 https://www.cityam.com/astrazeneca-vows-to-lower-us-medicine-prices-after-pressure-from-trump/ #news #tariffs #trump #donaldtrump #keirstarmer #starmer #politics #politicalnews #business #businessnews #economy #economics #trade #tradewar #tradedeal #uk #uknews #ukeconomy